VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr | ₹132 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹132 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 131.84 | |
| Mar2024 | ₹37 Cr | 1.80 | |
| Mar2023 | ₹37 Cr | -10.89 | |
| Mar2022 | ₹41 Cr | -68.82 | |
| Mar2021 | ₹132 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹955.6 Cr | -8.2% | 0.3% | 155.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -8.2% |
0.3% |
155.4% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses